ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

In Brief: Cooper Wouldn’t Take NIH Job, Says No One Has Asked Him To Take Top Health Spot

February 7, 1975

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984